White Matter Lesion Volumes on 3-T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than 10 Years.

IF 2.2 Q3 CLINICAL NEUROLOGY
Multiple Sclerosis International Pub Date : 2024-11-01 eCollection Date: 2024-01-01 DOI:10.1155/2024/8818934
Mariaan Jaftha, Frances Robertson, Susan J van Rensburg, Martin Kidd, Ronald van Toorn, Merlisa C Kemp, Clint Johannes, Kelebogile E Moremi, Lindiwe Whati, Maritha J Kotze, Penelope Engel-Hills
{"title":"White Matter Lesion Volumes on 3-T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than 10 Years.","authors":"Mariaan Jaftha, Frances Robertson, Susan J van Rensburg, Martin Kidd, Ronald van Toorn, Merlisa C Kemp, Clint Johannes, Kelebogile E Moremi, Lindiwe Whati, Maritha J Kotze, Penelope Engel-Hills","doi":"10.1155/2024/8818934","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b>: Cerebral white matter lesion (WML) formation in people with multiple sclerosis (pwMS) is linked to the death of myelin-producing oligodendrocytes. Current MS treatment strategies focus on limiting WML accumulation and disability. Using a pathology-supported genetic testing (PSGT) program, we identified specific risk factors for MS, categorized as <i>deficiencies</i> and <i>aggravators</i>. We developed a novel clinical methodology to mitigate these risk factors, including personalized lifestyle interventions and optimization of cerebral nutrients to prevent oligodendrocyte demise and promote remyelination. <b>Objective</b>: To conduct a pilot case-control study over a 10-year period to ascertain whether the PSGT Program can reduce or prevent WML formation in pwMS. <b>Methods</b>: MRI was performed at baseline as well as after an interval period of at least 10 years or longer in 22 pwMS. WML volumes were determined using Sequence Adaptive Multimodal SEGmentation (SAMSEG) software, part of FreeSurfer 7.2. Other variables included age at MRI, disease duration, disability status, and medication. <b>Results</b>: PwMS (<i>n</i> = 13) who had followed the PSGT program for more than 10 years, had significantly smaller lesion volumes (mm<sup>3</sup>) compared to pwMS who did not adhere to the program (<i>n</i> = 9) (4950 ± 5303 vs. 17934 ± 11139; <i>p</i> = 0.002). WML volumes were significantly associated (<i>p</i> = 0.02) with disability (EDSS) but not with age (<i>p</i> = 0.350), disease duration (<i>p</i> = 0.709), or Interferon-<i>β</i> treatment (<i>p</i> = 0.70). <b>Conclusion:</b> Dietary and lifestyle changes may lower the risk of developing cerebral WMLs in pwMS and potentially slow disease progression. Larger studies are required to confirm the effectiveness of such interventions in pwMS.</p>","PeriodicalId":46096,"journal":{"name":"Multiple Sclerosis International","volume":"2024 ","pages":"8818934"},"PeriodicalIF":2.2000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548950/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple Sclerosis International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/8818934","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cerebral white matter lesion (WML) formation in people with multiple sclerosis (pwMS) is linked to the death of myelin-producing oligodendrocytes. Current MS treatment strategies focus on limiting WML accumulation and disability. Using a pathology-supported genetic testing (PSGT) program, we identified specific risk factors for MS, categorized as deficiencies and aggravators. We developed a novel clinical methodology to mitigate these risk factors, including personalized lifestyle interventions and optimization of cerebral nutrients to prevent oligodendrocyte demise and promote remyelination. Objective: To conduct a pilot case-control study over a 10-year period to ascertain whether the PSGT Program can reduce or prevent WML formation in pwMS. Methods: MRI was performed at baseline as well as after an interval period of at least 10 years or longer in 22 pwMS. WML volumes were determined using Sequence Adaptive Multimodal SEGmentation (SAMSEG) software, part of FreeSurfer 7.2. Other variables included age at MRI, disease duration, disability status, and medication. Results: PwMS (n = 13) who had followed the PSGT program for more than 10 years, had significantly smaller lesion volumes (mm3) compared to pwMS who did not adhere to the program (n = 9) (4950 ± 5303 vs. 17934 ± 11139; p = 0.002). WML volumes were significantly associated (p = 0.02) with disability (EDSS) but not with age (p = 0.350), disease duration (p = 0.709), or Interferon-β treatment (p = 0.70). Conclusion: Dietary and lifestyle changes may lower the risk of developing cerebral WMLs in pwMS and potentially slow disease progression. Larger studies are required to confirm the effectiveness of such interventions in pwMS.

采用饮食和生活方式计划超过 10 年的多发性硬化症患者的 3 T MRI 白质病变体积。
背景:多发性硬化症患者脑白质病变(WML)的形成与产生髓鞘的少突胶质细胞的死亡有关。目前多发性硬化症的治疗策略主要是限制白质病变的积累和致残率。通过病理学支持的基因检测(PSGT)计划,我们确定了多发性硬化症的特定风险因素,分为缺陷和加重因素。我们开发了一种新颖的临床方法来减轻这些风险因素,包括个性化生活方式干预和优化大脑营养,以防止少突胶质细胞死亡并促进髓鞘再形成。研究目的开展一项为期 10 年的病例对照试点研究,以确定 PSGT 计划是否能减少或预防儿童髓鞘炎的形成。研究方法:在基线以及至少 10 年或更长的间隔期后,对 22 名 pwMS 进行磁共振成像。使用 FreeSurfer 7.2 的 Sequence Adaptive Multimodal SEGmentation (SAMSEG) 软件确定 WML 体积。其他变量包括核磁共振成像时的年龄、病程、残疾状况和用药情况。结果与未坚持 PSGT 计划的患者(n = 9)相比,坚持 PSGT 计划超过 10 年的患者(n = 13)的病灶体积(mm3)明显较小(4950 ± 5303 vs. 17934 ± 11139;p = 0.002)。WML 体积与残疾程度(EDSS)明显相关(p = 0.02),但与年龄(p = 0.350)、病程(p = 0.709)或干扰素-β 治疗(p = 0.70)无关。结论饮食和生活方式的改变可能会降低帕金森病患者罹患脑WMLs的风险,并有可能减缓疾病的进展。需要进行更大规模的研究,以确认此类干预措施对 pwMS 的有效性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Multiple Sclerosis International
Multiple Sclerosis International CLINICAL NEUROLOGY-
自引率
0.00%
发文量
6
审稿时长
15 weeks
期刊介绍: Multiple Sclerosis International is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to all aspects of multiple sclerosis, including clinical neurology, neuroimaging, neuropathology, therapeutics, genetics, neuroimmunology, biomarkers, psychology and neurorehabilitation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信